Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B Kirkham
FRI0494 Secukinumab Provides Rapid and Sustained Pain Relief in Psoriatic Arthritis: 2-Year Results From the Future 2 Study
Discovertebral Destruction in Ankylosing Spondylitis Complicated by Spinal Cord Compression.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Related publications
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5‐year Results From the Phase 3 FUTURE 1 Study
ACR Open Rheumatology
THU0369 Secukinumab 150mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis With High Retention Rate: 3-Year Results From Phase Iii Trial, Measure 2
Progression of Fibromyalgia: Results From a 2-Year Observational Fibromyalgia and Chronic Pain Study in the US
Journal of Pain Research
Anesthesiology
Pain Medicine
Interleukin-17inhibition With Secukinumab Improves Sudomotor Dysfunction in Psoriatic Arthritis
International Journal of Pharmacy and Pharmaceutical Sciences
Pharmacology
Pharmaceutical Science
Real-World Data on Secukinumab Use for Psoriatic Arthritis and Ankylosing Spondylitis
Therapeutic Advances in Musculoskeletal Disease
Rheumatology
Orthopedics
Sports Medicine
Certolizumab Pegol Is Associated With Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis: 4-Year Outcomes From the Rapid-Psa Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Decreased Use of Glucocorticoids in Biological-Experienced Patients With Rheumatoid Arthritis Who Initiated Intravenous Abatacept: Results From the 2-Year ACTION Study
RMD Open
Rheumatology
Allergy
Immunology
Cardiovascular Risk Management in Rheumatoid and Psoriatic Arthritis: Online Survey Results From a National Cohort Study
BMC Rheumatology
Rheumatology
Matching-Adjusted Indirect Comparison: Secukinumab Versus Infliximab in Biologic-Naive Patients With Psoriatic Arthritis
Journal of Comparative Effectiveness Research
Health Policy
